PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility - Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products
Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/01/30 - Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products and strategic expansion across European and global infertility treatment markets

Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership.

The European hormone products market for infertility has been relatively stagnant over a decade with less differentiation in terms of product characteristics and delivery mechanisms. Merck Serono, by virtue of its comprehensive range of innovative and unique products and advanced delivery systems aimed at improving therapeutic efficacy and patient compliance, has managed to stay ahead of its competitors in the European as well as global infertility therapeutics market.

Besides having one of the most varied product portfolios in the infertility therapeutics market, Merck Serono has been making substantial efforts to meet customers’ needs.” said Frost & Sullivan Research Analyst Aiswariya Chidambaram. “This is evident from the development of its new pre-filled, ready-to-use pen injectors for the administration of the three recombinant hormone products needed to treat infertility, which were recently approved by the Health Authorities.”

“Additionally, the company has always been proactive in expanding its global footprint and exploring new market opportunities through strategic alliances with ideal partners in the pharmaceutical and biotechnology industries”, remarks Chidambaram. “Similarly, Merck Serono has always remained pro-active in encouraging and nurturing innovation by funding innovative research projects and launching informative websites for the benefit of the patients.”

Each year, Frost & Sullivan presents this award to the company whose competitive strategy yields significant gains in market share. The recognized company takes advantage of recent market changes that facilitate the introduction of novel methods of capturing and solidifying market presence. Alternatively, the award recipient has executed an innovative strategy within the existing competitive landscape. In either case, the company captures the attention of the competition, which quickly adjusts to protect its own market position. Frost & Sullivan analysts expect such innovations to produce lasting, precedent-setting trends in the industry.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Emily Bailey 
+44(0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Research Most Recent Related Newswires:

DSM Launches New Enzyme Solutions At IFT17 to Improve Softness and Moistness of Gluten-free Bread
DSM and Evonik Select Nebraska for Production of Breakthrough Omega-3
Phasor to Develop Next Generation Electronically Steerable Antenna Featuring DSM Dyneema’s Advanced Radome Solution
DSM’s Delvotest® T Antibiotic Residue Test for Milk Validated by Finnish Food Safety Authority
Royal DSM to Make Equity Investment in Amyris with the Purpose of Establishing A Long-term Relationship
DSM Unveils New Beauty Active At NYSCC Suppliers’ Day
Iridea Bio - A New Sustainable Paint Made with DSM’s Decovery® Plant-based Resin
DSM to Showcase A Wide Range of Innovative Composite Solutions
DSM’s New Protective Delvo®Guard Cultures Reduce Food Waste in Dairy
DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids from Natural Marine Algae for Animal Nutrition
DSM Introduces Dyneema Purity® Black Fiber - The First Black Medical-grade UHMWPE Fiber
Research by German Wildau Technical University Confirms Long-term Performance of Dyneema® Soft Ballistics for Use in Bullet Resistant Vests
DSM Dyneema Wins Significant Patent Case in Israel
Actamax™ Submits IDE to FDA for Pivotal Study on Novel Sprayable Adhesion Barrier Device
POET-DSM Plans On-site Enzyme Manufacturing Facility At Project Liberty

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)